Fritextsökning
Artiklar per år
Innehållstyper
-
Forskningsstöd missgynnar kvinnor
Fler män får stöd, och de får i genomsnitt mer pengar. De danska forskningsrådens sätt att fördela pengar förstärker könsskillnaderna i forskningsvärlden, enligt en ny rapport.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study will try to evaluate this, and one thousand people are to be included.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Bio-Linux goes global
Recently the NEBC Bio-Linux Version 5.0 was released, a one-stop shop for bioinformatics tools in a Linux context.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antibiotic-resistant bacteria. That is stated in a report commissioned by the Swedish government.
BREAKING